Concepedia

Author

John Treanor

University of Rochester Medical Center

Also Known As

J Treanor, John T. Treanor, John Treanor

11

Publications

1.3K

Citations

8

H-Index

13

Concepts

All Affiliations

University of Rochester Medical CenterCincinnati Children's Hospital Medical CenterSaint Louis University
JT

About

John Treanor is an author at University of Rochester Medical Center specializing in vaccination, vaccine development, and influenza vaccines.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

708

2

Immunology

2

2

278

3

Allergy

1

1

22

4

Epidemiology

1

1

256

5

Emerging Infectious Diseases

1

1

256

John Treanor

×

8

Publications

1.3K

Citations

8

H-Index

YearCitations

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

Robert B. Belshe, William C. Gruber, Paul M. Mendelman,

The Journal of Pediatrics

2000

430

Serum Antibody Responses after Intradermal Vaccination against Influenza

Robert B. Belshe, Frances K. Newman, Joan C. Cannon,

New England Journal of Medicine

2004

330

Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift

John Treanor

New England Journal of Medicine

2004

256

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff,

Vaccine

2013

162

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

Kathryn E. Stephenson, Michael C. Keefer, Catherine A. Bunce,

PLoS ONE

2018

36

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study

John Treanor, Frank R. Albano, Daphne Sawlwin,

Vaccine

2017

34

A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose

John Treanor, Jim Sherwood, Jakob P. Cramer,

Vaccine

2020

32

A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults

Scott A. Halperin, Bruce R. Smith, Kevin Clarke,

Human Vaccines

2005

22

Page 1